MedPath

Prevalence of Keratoconus in Inflammatory Bowel Diseases

Not Applicable
Completed
Conditions
Inflammatory Bowel Diseases
Keratoconus
Interventions
Device: Opthalmologic measure with DM OPD scan III (Nidek)
Registration Number
NCT02861339
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

A retrospective study has shown the association between the inflammatory bowel diseases (IBD) and the presence of a keratoconus. This new study will measure the prevalence of keratoconus and follow its activity in patients affected by IBD and followed up in hepatology-gastroenterology department at Nancy Hospital. The prevalence of keratoconus will be compared to known data of literature about general population.

The secondary purpose is to search for a relationship between the presence of a keratoconus and activity criteria of IBD.

Perspectives are a systematic screening for keratoconus in patients affected by IBD with the amelioration of the ophthalmologic care of IBD patients and confirmation of the recent hypothesis of inflammatory origin of keratoconus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
201
Inclusion Criteria
  • Informed consent
  • Affiliation to social security plan
  • Diagnosis of IBD since more than 3 years, under treatment or not
Exclusion Criteria
  • Protected person
  • Pregnant or breastfeeding women
  • Person in life-and-death emergency
  • Person deprived of liberty
  • Refusal to remove contact lenses, where necessary

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Keratoconus and IBDOpthalmologic measure with DM OPD scan III (Nidek)Opthalmologic measure with DM OPD scan III (Nidek)
Primary Outcome Measures
NameTimeMethod
Absence or presence of keratoconus in IBD patientsday 0

Data from OPD scan III corneal analyzer according to Rabinowitz and Klyce Maeda criteria. The presence of a keratoconus in at least one eye is considered positive.

Secondary Outcome Measures
NameTimeMethod
IBD clinical features using the Montreal classification for IBDday 0
© Copyright 2025. All Rights Reserved by MedPath